RN Mobile Menu

Search form


Juvenile Arthritis

Juvenile Arthritis


Identifying macrophage activation syndrome (MAS) in JIA early is challenging. This study suggests re-classifying the criteria for MAS to aid research.


Organized collaborations and advances in technology have contributed to improved treatment of rheumatic diseases that affect children.


A task force of rheumatologists, radiologists and patients has developed nine points to consider in the clinical management of juvenile idiopathic arthritis.


Repetitive intraarticular corticosteroid injections to the temporomandibular joint do not prevent progressive osseous deformation nor normalize mandibular growth in children with juvenile idiopathic arthritis.


Distinguishing between different types of childhood arthritis is not always easy.

Biologics for systemic juvenile idiopathic arthritis lead to inactive disease status and remission for some patients.

Researchers from Children’s Hospital of Philadelphia suggest that rheumatologists consider screening children with juvenile spondyloarthritis for sacroiliitis, but especially children who carry the HLA-B27 gene form of the disease with elevated C-reactive protein levels.


Subscribe to Juvenile Arthritis on [sitename]

By clicking Accept, you agree to become a member of the UBM Medica Community.